Qiagen N.V.
Provides 'Sample to Insight' solutions for molecular analysis in research and clinical healthcare.
QIA | F
Overview
Corporate Details
- ISIN(s):
- DE000A286LP0 (+5 more)
- LEI:
- 54930036WK3GMCN17Z57
- Country:
- Netherlands
- Address:
- HULSTERWEG 82, 5912 PL VENLO
- Website:
- https://www.qiagen.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Qiagen N.V. is a leading global provider of integrated "Sample to Insight" solutions designed to enable customers to gain valuable molecular insights from biological samples. The company's comprehensive portfolio covers the entire molecular testing workflow, from sample preparation technologies that isolate DNA, RNA, and proteins, to assay technologies and automated instrumentation for analysis. Qiagen also provides bioinformatics software to interpret the resulting data. Its products are utilized by a diverse customer base across molecular diagnostics, academic research, pharmaceutical development, and applied testing, facilitating advancements in life sciences and clinical healthcare.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-06 00:00 |
Foreign Filer Report
Q3 statement / Q3 financial report 2025
|
English | 896.5 KB | ||
| 2025-11-04 19:02 |
Board/Management Information
QIAGEN N.V.: QIAGEN announces CEO transition plan
|
English | 6.5 KB | ||
| 2025-09-30 11:25 |
Interim / Quarterly Report
Qiagen N.V., Halfjaarlijkse financiële verslaggeving
|
English | 268.3 KB | ||
| 2025-08-28 07:57 |
Capital/Financing Update
QIAGEN N.V.: QIAGEN N.V. launches non-US offering of net share settled converti…
|
English | 18.4 KB | ||
| 2025-08-22 00:00 |
Foreign Filer Report
Half-yearly financial report 2025
|
English | 428.1 KB | ||
| 2025-05-13 00:00 |
Foreign Filer Report
Q1 statement / Q1 financial report 2025
|
English | 693.8 KB | ||
| 2025-05-07 14:35 |
Notice of Dividend Amount
QIAGEN N.V.: QIAGEN to propose initiation of annual cash dividend for sharehold…
|
English | 6.8 KB | ||
| 2025-04-28 16:33 |
Annual Report (ESEF)
Qiagen N.V., Jaarlijkse financiële verslaggeving
|
English | 23.4 MB | ||
| 2025-04-06 18:20 |
Earnings Release
QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates fu…
|
English | 7.2 KB | ||
| 2025-03-31 00:00 |
Annual Report
Annual financial report 2024
|
English | 6.2 MB | ||
| 2025-02-06 06:31 |
Earnings Release
QIAGEN delivers solid Q4 2024 growth ahead of outlook
|
English | 478.9 KB | ||
| 2025-01-13 18:55 |
Transaction in Own Shares
QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders throug…
|
English | 7.7 KB | ||
| 2025-01-12 18:55 |
Share Issue/Capital Change
QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders throug…
|
English | 7.7 KB | ||
| 2024-11-07 07:30 |
Earnings Release
QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024…
|
English | 421.6 KB | ||
| 2024-09-03 09:01 |
Capital/Financing Update
QIAGEN N.V. launches non-US offering of net share settled convertible bonds
|
English | 56.8 KB |
Automate Your Workflow. Get a real-time feed of all Qiagen N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Qiagen N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Qiagen N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-04-17 | S. Rusckowski | Non-Executive member | Other | 26 | N/A |
| 2023-03-14 | E.R. Mardis | Non-Executive member | Sell | 4,739 | 218,422.41 USD |
| 2023-02-28 | E. Pisa | Non-Executive member | Other | 7,917 | N/A |
| 2023-02-21 | R. Sackers | Non-Executive member | Other | 51,500 | N/A |
| 2022-12-01 | R. Sackers | Non-Executive member | Sell | 30,000 | 1,500,000.00 USD |
| 2022-10-31 | M. Colpan | Non-Executive member | Other | 457 | N/A |
| 2022-06-08 | R. Sackers | Non-Executive member | Sell | 32,398 | 1,522,706.00 USD |
| 2022-03-31 | R. Sackers | Non-Executive member | Other | 72,944 | N/A |
| 2022-03-15 | R. Sackers | Non-Executive member | Other | 7,606 | N/A |
| 2022-03-14 | E.R. Mardis | Non-Executive member | Sell | 5,003 | 228,330.77 USD |
Peer Companies
